Autres langues LBT Innovations Limited

Actions

LBT

AU000000LBT8

Marché Fermé - Australian S.E. Autres places de cotation 07:56:00 03/05/2024			Varia. 5j.	Varia. 1 janv.
0,019 ^AUD	0,00%		-5,00%	+72,73%

13/03	Les actions australiennes suivent les gains de leurs homologues de Wall Street alors que le marché réagit aux données sur l'inflation américaine	MT
13/03	L'APAS PharmaQC de LBT Innovations achève sa validation primaire ; les actions grimpent de 79%.	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

LBT Innovations Sells APAS Independence Instrument to NovaCina	29/04
Australian Shares Track Gains of Wall Street Peers as Market Shrugs Off US Inflation Data	13/03
LBT Innovations' APAS PharmaQC Completes Primary Validation; Shares Up 79%	13/03
LBT Innovations Delivers APAS Hardware, Software to Thermo Fisher	23/02
LBT Innovations Limited Reports Earnings Results for the Half Year Ended December 31, 2023	22/02
LBT Innovations Makes First Sale of APAS PharmaQC; Shares Jump 31%	22/02
LBT Innovations Limited Appoints Dan Hill as Non-Executive Director	13/12
LBT Innovations Limited Announces Retirement of Damian Lismore as Director. Effective 29 November 2023	26/11
LBT Innovations Secures Approval for AU$1.7 Million Loan Restructuring	06/11
LBT Innovations Fully Repays Share Placement Facility	13/10/23
LBT Innovations Raising Up to AU$4.5 Million Via Entitlement Offer; Shares Down 27%	13/10/23
LBT Innovations Secures R&D Tax Refund for Fiscal Year 2023; Shares Rally 11%	05/09/23
LBT Innovations Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31/08/23
LBT Innovations Flags AU$13 Million Impairment Charge	04/08/23
LBT Innovations Limited Appoints Rebecca Wilson as Director	05/07/23
LBT Innovations Appoints Chair; Shares Jump 7%	03/07/23
LBT Innovations Limited Announces the Retirement of Simon Arkell as Non-Executive Director	30/03/23
LBT Innovations Limited Reports Earnings Results for the Half Year Ended December 31, 2022	28/02/23
AddLife strengthens the organization for future growth	13/02/23
LBT Innovations, AstraZeneca Partner to Develop APAS Pharma Product	09/01/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues LBT Innovations Limited

Actions

LBT

AU000000LBT8

Autres langues

Filtres